The European Lead Factory builds on an established partnership between public and private organisations, designed to promote innovation by ensuring in-depth collaboration, honest brokerage and enhanced communication.

With currently 20 international partners and 14 former partners, the EU Lead Factory capitalises on the innovation of academia, the agility of small- and medium-sized enterprises (SMEs) and the experience and resources of the large pharmaceutical partners that are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Governance and funding

The European Lead Factory is funded by the Innovative Medicines Initiative (IMI) Joint Undertaking, and by the IMI2 Joint Undertaking under ‘ESCulab: European Screening Centre; Unique Library for Attractive Biology’. The Joint Undertaking receives support from the EU’s Horizon 2020 research and innovation programme, and EFPIA and the Medicines for Malaria Venture (MMV). The 8 pharmaceutical partners provide in-kind contributions. The European Lead Factory is governed by the Project Management Board and the Project General Assembly. Lygature is the project coordinator and Bayer the project leader.